Keel Point, LLC Novo Nordisk A S Transaction History

Keel Point, LLC

$1.19 Billion
Q3 2024

A detailed history of Keel Point, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Keel Point, LLC holds 9,664 shares of NVO stock, worth $850,142. This represents 0.1% of its overall portfolio holdings.

Number of Shares

9,664

Previous 9,674 0.1%

Holding current value

$850,142

Previous $1.38 Million 16.67%

% of portfolio

0.1%

Previous 0.12%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$119.07 - $145.42 $1,190 - $1,454	-10 Reduced 0.1%	9,664 $1.15 Million
Q2 2024 Aug 14, 2024	BUY	$122.71 - $146.91 $228,608 - $273,693	1,863 Added 23.85%	9,674 $1.38 Million
Q1 2024 Apr 16, 2024	BUY	$102.11 - $135.92 $110,993 - $147,745	1,087 Added 16.17%	7,811 $1 Million
Q4 2023 Jan 30, 2024	BUY	$87.78 - $105.45 $42,924 - $51,565	489 Added 7.84%	6,724 $695,000
Q3 2023 Oct 26, 2023	BUY	$90.94 - $199.54 $276,912 - $607,599	3,045 Added 95.45%	6,235 $567,000
Q2 2023 Jul 12, 2023	SELL	$155.98 - $172.65 $50,225 - $55,593	-322 Reduced 9.17%	3,190 $516,000
Q1 2023 Apr 03, 2023	SELL	$132.34 - $159.14 $18,792 - $22,597	-142 Reduced 3.89%	3,512 $558,000
Q4 2022 Jan 17, 2023	BUY	$102.55 - $135.33 $31,585 - $41,681	308 Added 9.21%	3,654 $0
Q3 2022 Oct 05, 2022	BUY	$95.28 - $116.93 $4,001 - $4,911	42 Added 1.27%	3,346 $333,000
Q2 2022 Aug 11, 2022	BUY	$103.24 - $121.81 $6,400 - $7,552	62 Added 1.91%	3,304 $355,000
Q1 2022 Apr 27, 2022	SELL	$93.1 - $112.54 $155,756 - $188,279	-1,673 Reduced 34.04%	3,242 $360,000
Q4 2021 Jan 31, 2022	SELL	$95.88 - $117.08 $33,078 - $40,392	-345 Reduced 6.56%	4,915 $550,000
Q3 2021 Nov 04, 2021	BUY	$84.42 - $106.62 $444,049 - $560,821	5,260 New	5,260 $505,000
Q2 2021 Aug 06, 2021	BUY	$67.66 - $84.76 $3,450 - $4,322	51 Added 0.99%	5,201 $436,000
Q2 2021 Aug 06, 2021	SELL	$67.66 - $84.76 $351,899 - $440,836	-5,201 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$67.06 - $75.82 $75,174 - $84,994	1,121 Added 27.82%	5,150 $347,000
Q4 2020 Feb 10, 2021	BUY	$63.89 - $73.8 $13,033 - $15,055	204 Added 5.33%	4,029 $281,000
Q3 2020 Nov 18, 2020	BUY	$63.69 - $70.22 $243,614 - $268,591	3,825 New	3,825 $266,000
Q2 2020 Aug 14, 2020	SELL	$58.54 - $67.94 $276,308 - $320,676	-4,720 Closed	0 $0
Q1 2020 May 01, 2020	SELL	$49.46 - $64.78 $14,739 - $19,304	-298 Reduced 5.94%	4,720 $284,000
Q4 2019 Feb 07, 2020	SELL	$49.86 - $58.26 $64,020 - $74,805	-1,284 Reduced 20.37%	5,018 $290,000
Q3 2019 Nov 12, 2019	BUY	$47.54 - $53.43 $332 - $374	7 Added 0.11%	6,302 $326,000
Q2 2019 Aug 08, 2019	BUY	$46.79 - $52.47 $561 - $629	12 Added 0.19%	6,295 $321,000
Q1 2019 May 14, 2019	SELL	$46.36 - $52.63 $23,180 - $26,315	-500 Reduced 7.37%	6,283 $329,000
Q4 2018 Feb 08, 2019	SELL	$41.54 - $47.25 $2,077 - $2,362	-50 Reduced 0.73%	6,783 $313,000
Q3 2018 Nov 07, 2018	BUY	$46.76 - $51.24 $467 - $512	10 Added 0.15%	6,833 $322,000
Q2 2018 Aug 13, 2018	BUY	$44.29 - $50.42 $2,878 - $3,277	65 Added 0.96%	6,823 $315,000
Q3 2017 Nov 09, 2017	BUY	$41.15 - $49.22 $411 - $492	10 Added 0.15%	6,758 $325,000
Q2 2017 Aug 15, 2017	BUY	N/A	6,748	6,748 $289,000

Others Institutions Holding NVO

# of Institutions

1,904

Shares Held

317M

Call Options Held

5.49M

Put Options Held

7.77M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $199B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Keel Point, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Keel Point, LLC with notifications on news.

Account